118 related articles for article (PubMed ID: 38697470)
1. Tanshinone IIA alleviates pulmonary fibrosis by modulating glutamine metabolic reprogramming based on [U-
Shan B; Guo C; Zhou H; Chen J
J Adv Res; 2024 May; ():. PubMed ID: 38697470
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA ameliorates energy metabolism dysfunction of pulmonary fibrosis using
Shan B; Zhou H; Guo C; Liu X; Wu M; Zhai R; Chen J
J Pharm Anal; 2024 Feb; 14(2):244-258. PubMed ID: 38464785
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA Activates Nuclear Factor-Erythroid 2-Related Factor 2 to Restrain Pulmonary Fibrosis via Regulation of Redox Homeostasis and Glutaminolysis.
An L; Peng LY; Sun NY; Yang YL; Zhang XW; Li B; Liu BL; Li P; Chen J
Antioxid Redox Signal; 2019 May; 30(15):1831-1848. PubMed ID: 30105924
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA Regulates Keap1/Nrf2 Signal Pathway by Activating Sestrin2 to Restrain Pulmonary Fibrosis.
Li H; Wu M; Guo C; Zhai R; Chen J
Am J Chin Med; 2022; 50(8):2125-2151. PubMed ID: 36309810
[TBL] [Abstract][Full Text] [Related]
5. Glutamine Metabolism Is Required for Collagen Protein Synthesis in Lung Fibroblasts.
Hamanaka RB; O'Leary EM; Witt LJ; Tian Y; Gökalp GA; Meliton AY; Dulin NO; Mutlu GM
Am J Respir Cell Mol Biol; 2019 Nov; 61(5):597-606. PubMed ID: 30973753
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via inhibition of TGF-β1-Smad signaling pathway.
Feng F; Li N; Cheng P; Zhang H; Wang H; Wang Y; Wang W
Biomed Pharmacother; 2020 Jan; 121():109586. PubMed ID: 31706104
[TBL] [Abstract][Full Text] [Related]
7. The Protective Role of Tanshinone IIA in Silicosis Rat Model via TGF-β1/Smad Signaling Suppression, NOX4 Inhibition and Nrf2/ARE Signaling Activation.
Feng F; Cheng P; Zhang H; Li N; Qi Y; Wang H; Wang Y; Wang W
Drug Des Devel Ther; 2019; 13():4275-4290. PubMed ID: 31908414
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA ameliorates the development of dermal fibrosis in systemic sclerosis.
Jiang Y; Hu F; Li M; Li Q
Clin Exp Pharmacol Physiol; 2024 Feb; 51(2):e13834. PubMed ID: 38037494
[TBL] [Abstract][Full Text] [Related]
10. Glutaminolysis is required for transforming growth factor-β1-induced myofibroblast differentiation and activation.
Bernard K; Logsdon NJ; Benavides GA; Sanders Y; Zhang J; Darley-Usmar VM; Thannickal VJ
J Biol Chem; 2018 Jan; 293(4):1218-1228. PubMed ID: 29222329
[TBL] [Abstract][Full Text] [Related]
11. Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis.
Henderson J; Duffy L; Stratton R; Ford D; O'Reilly S
J Cell Mol Med; 2020 Dec; 24(23):14026-14038. PubMed ID: 33140521
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling.
Feng F; Cheng P; Xu S; Li N; Wang H; Zhang Y; Wang W
Chem Biol Interact; 2020 Mar; 319():109024. PubMed ID: 32097614
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA Liposomes Treat Doxorubicin-Induced Glomerulonephritis by Modulating the Microenvironment of Fibrotic Kidneys.
Dong T; Yang N; Qin J; Zhao C; Gao T; Ma H; Zhu C; Xu H
Mol Pharm; 2024 Jun; ():. PubMed ID: 38848439
[TBL] [Abstract][Full Text] [Related]
14. Intervention of Tanshinone IIA on the PGK1-PDHK1 Pathway to Reprogram Macrophage Phenotype After Myocardial Infarction.
Gao S; Yang Z; Li D; Wang B; Zheng X; Li C; Fan G
Cardiovasc Drugs Ther; 2023 Nov; ():. PubMed ID: 37991600
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA Inhibits High Glucose-Induced Collagen Synthesis via Nuclear Factor Erythroid 2-Related Factor 2 in Cardiac Fibroblasts.
Tsai YT; Loh SH; Lee CY; Lee SP; Chen YL; Cheng TH; Tsai CS
Cell Physiol Biochem; 2018; 51(5):2250-2261. PubMed ID: 30537733
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of Tanshinone IIA on inverted formin-2 protects HaCaT cells against oxidative injury via regulating mitochondrial stress.
Xie Z; Zhou Y; Duan X; Yang L
J Recept Signal Transduct Res; 2019 Apr; 39(2):134-145. PubMed ID: 31354004
[No Abstract] [Full Text] [Related]
17. Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC.
Liu W; Le A; Hancock C; Lane AN; Dang CV; Fan TW; Phang JM
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):8983-8. PubMed ID: 22615405
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA reverses EGF- and TGF-β1-mediated epithelial-mesenchymal transition in HepG2 cells via the PI3K/Akt/ERK signaling pathway.
Zhang L; Lin W; Chen X; Wei G; Zhu H; Xing S
Oncol Lett; 2019 Dec; 18(6):6554-6562. PubMed ID: 31807174
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA prevents LPS-induced inflammatory responses in mice via inactivation of succinate dehydrogenase in macrophages.
Liu QY; Zhuang Y; Song XR; Niu Q; Sun QS; Li XN; Li N; Liu BL; Huang F; Qiu ZX
Acta Pharmacol Sin; 2021 Jun; 42(6):987-997. PubMed ID: 33028985
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA alleviates bleomycin-induced pulmonary fibrosis by inhibiting Zbtb16.
Zhang H; Qiu J; Zhao Q; Zhang Y; Zheng H; Dou Z; Yan Y
Pulm Pharmacol Ther; 2024 Mar; 84():102285. PubMed ID: 38191069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
